PDCD1 and neoplasm: demonstrated that the anti-tumor immune responses to combined radiation and PD-1 inhibition in their HNSCC mouse model were ultimately transient, as compensatory mechanisms of immune evasion were activated, including upregulation of another immune checkpoint, TIM-3, as well as increased tumor infiltration of Tregs (39, 43).